US benchmark equity indexes ended mixed Monday as markets awaited inflation data and bank earnings due later in the week.

* The official US producer price report for December is scheduled to be released Tuesday, followed by consumer inflation data on Wednesday. Meanwhile JPMorgan Chase (JPM), Bank of America (BAC), Wells Fargo (WFC), Morgan Stanley (MS), Goldman Sachs (GS), and Citigroup (C) are set to report quarterly financial results later this week.

* US consumers' median inflation expectations were unchanged at 3% at the one-year horizon in December, a survey by the Federal Reserve Bank of New York showed. The inflation outlooks rose to 3% from 2.6% at the three-year horizon and dropped to 2.7% from 2.9% at the five-year horizon.

* February West Texas Intermediate crude oil closed up $2.18 to settle at $78.75 per barrel, while March Brent crude, the global benchmark, was last seen up $1.13 to $80.89 as traders assess the risk to supply following tightened U.S. sanctions on Russia's oil exports.

* Moderna (MRNA) shares slumped 17% after the drugmaker cut its full-year revenue outlook. The company said it aims to reduce cash costs by $1 billion in 2025.

* Johnson & Johnson (JNJ) agreed to acquire Intra-Cellular Therapies (ITCI) for $14.6 billion in cash to strengthen its neuroscience portfolio. Johnson & Johnson shares rose 1.7%, and Intra-Cellular surged 34%.